Public-registry trials using CAB-AXL-ADC that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC | BioAtla, Inc. | Non-Small-Cell Lung Cancer | PHASE2 | 60 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →